Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay. More...
17 Apr 2026
Image: The Content Innovation Engine integrates spatial biology technology with the company’s established expertise in ultra-sensitive, quantitative immunoassay development based on Simoa technology (photo courtesy of Quanterix)

Quanterix Launches Integrated Spatial Biology Platform for Cancer Research

Quanterix will debut its Content Innovation Engine at AACR 2026, unifying spatial biology with ultra-sensitive immunoassay capabilities to support translational and clinical applications. More...
17 Apr 2026
Image: NTU Assoc Prof Y.C. Chen (right) holding the new biochip, which can detect miRNA in 20 minutes using AI, with his PhD student Fu Bowen behind him (left) (photo courtesy of Nanyang Technological University)

AI-Enabled Biochip Detects microRNA Biomarkers in Minutes

An AI-enabled nanophotonic biochip detects multiple microRNAs from blood in 20 minutes, speeding lab workflows. More...
17 Apr 2026

QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026

The showcase highlights integrated technologies in cancer research and molecular diagnostics. More...
17 Apr 2026
Image: (From left to right) Nizar Bahlis, MD, Holly Lee, MD, Paola Neri, MD, Ph.D. (photo courtesy of Riley Brandt, University of Calgary)

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma

New findings show how myeloma cells adapt following immunotherapy, revealing mechanisms linked to relapse. More...
17 Apr 2026
Image: The assay evaluates multiple cancer‑associated signals together to support risk assessment for early detection (photo credit: Adobe Stock)

Blood Test Detects Early Pancreatic Cancer in High-Risk Patients

A new multi‑signal blood test detects pancreatic cancer earlier in high‑risk patients, 82.6% sensitivity and 97.5% specificity. More...
17 Apr 2026
DB function failed with error number 0

Host–Virus Genetic Interactions Drive Nasopharyngeal Cancer Risk

More...
17 Apr 2026
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Copyright © 2000-2026 Globetech Media. All rights reserved.